MedPath

Clinical observation of Wumei formula granules regulating Glu/GABA-Gln metabolic circuit and HPA axis in the treatment of insomnia in Jueyin syndrome

Phase 1
Conditions
insomnia
Registration Number
ITMCTR2100004986
Lead Sponsor
the Second Affiliated Hospital of Dalian Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Aged 18-70 years old;
2. Meet the diagnostic criteria of traditional Chinese medicine and the diagnostic criteria of western medicine for insomnia;
3. Sign the informed consent and voluntarily join the clinical research observation;
4. Be able to understand the research content and have normal communication and comprehension skills;
5. Have not used related drugs for the treatment of insomnia, including traditional Chinese medicine, proprietary Chinese medicine and western medicine in the past 1 week.

Exclusion Criteria

1. Those who are allergic to umeboshi formula granules;
2. Exclude organic brain diseases: such as Parkinson's, dementia, cerebrovascular disease, etc.: exclude insomnia caused by organic diseases: such as restless legs syndrome, periodic limb movements, OSAS, parasomnia, hypothyroidism, Hyperthyroidism, alcohol dependence, etc.
3. There are obvious systemic pain, fever and infection and other diseases;
4. Patients with insomnia due to obvious environmental interference or due to alcohol, coffee, drug dependence or mental disorders;
5. Those who are currently taking drugs that affect sleep structure.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
adrenocorticotropic hormone;GABA;cortisol hormone;Glutamate;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath